Li Z - Search Results

1

Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death.

Li Z, Ma R, Tang H, Guo J, Shah Z, Zhang J, Liu N, Cao S, Marcucci G, Artis D, Caligiuri MA, Yu J. Li Z, et al. Cell. 2024 Feb 1;187(3):624-641.e23. doi: 10.1016/j.cell.2023.12.015. Epub 2024 Jan 10. Cell. 2024. PMID: 38211590

2

Cbl-b Is Upregulated and Plays a Negative Role in Activated Human NK Cells.

Lu T, Chen L, Mansour AG, Yu MJ, Brooks N, Teng KY, Li Z, Zhang J, Barr T, Yu J, Caligiuri MA. Lu T, et al. Among authors: li z. J Immunol. 2021 Feb 15;206(4):677-685. doi: 10.4049/jimmunol.2000177. Epub 2021 Jan 8. J Immunol. 2021. PMID: 33419766 Free PMC article.

3

An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma.

Ma R, Lu T, Li Z, Teng KY, Mansour AG, Yu M, Tian L, Xu B, Ma S, Zhang J, Barr T, Peng Y, Caligiuri MA, Yu J. Ma R, et al. Among authors: li z. Cancer Res. 2021 Jul 1;81(13):3635-3648. doi: 10.1158/0008-5472.CAN-21-0035. Epub 2021 May 18. Cancer Res. 2021. PMID: 34006525 Free PMC article.

4

Hijacking TYRO3 from Tumor Cells via Trogocytosis Enhances NK-cell Effector Functions and Proliferation.

Lu T, Ma R, Li Z, Mansour AG, Teng KY, Chen L, Zhang J, Barr T, Caligiuri MA, Yu J. Lu T, et al. Among authors: li z. Cancer Immunol Res. 2021 Oct;9(10):1229-1241. doi: 10.1158/2326-6066.CIR-20-1014. Epub 2021 Jul 29. Cancer Immunol Res. 2021. PMID: 34326137 Free PMC article.

5

ILC1s control leukemia stem cell fate and limit development of AML.

Li Z, Ma R, Ma S, Tian L, Lu T, Zhang J, Mundy-Bosse BL, Zhang B, Marcucci G, Caligiuri MA, Yu J. Li Z, et al. Nat Immunol. 2022 May;23(5):718-730. doi: 10.1038/s41590-022-01198-y. Epub 2022 Apr 29. Nat Immunol. 2022. PMID: 35487987 Free PMC article.

6

Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19.

Lu T, Ma R, Dong W, Teng KY, Kollath DS, Li Z, Yi J, Bustillos C, Ma S, Tian L, Mansour AG, Li Z, Settles EW, Zhang J, Keim PS, Barker BM, Caligiuri MA, Yu J. Lu T, et al. Among authors: li z. Nat Commun. 2022 May 11;13(1):2576. doi: 10.1038/s41467-022-30216-8. Nat Commun. 2022. PMID: 35546150 Free PMC article.

7

Publisher Correction: ILC1s control leukemia stem cell fate and limit development of AML.

Li Z, Ma R, Ma S, Tian L, Lu T, Zhang J, Mundy-Bosse BL, Zhang B, Marcucci G, Caligiuri MA, Yu J. Li Z, et al. Nat Immunol. 2022 Aug;23(8):1286. doi: 10.1038/s41590-022-01265-4. Nat Immunol. 2022. PMID: 35705798 No abstract available.

8

Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity.

Tian L, Xu B, Chen Y, Li Z, Wang J, Zhang J, Ma R, Cao S, Hu W, Chiocca EA, Kaur B, Caligiuri MA, Yu J. Tian L, et al. Among authors: li z. Nat Cancer. 2022 Nov;3(11):1318-1335. doi: 10.1038/s43018-022-00448-0. Epub 2022 Nov 10. Nat Cancer. 2022. PMID: 36357700 Free PMC article.

9

The emerging field of oncolytic virus-based cancer immunotherapy.

Ma R, Li Z, Chiocca EA, Caligiuri MA, Yu J. Ma R, et al. Among authors: li z. Trends Cancer. 2023 Feb;9(2):122-139. doi: 10.1016/j.trecan.2022.10.003. Epub 2022 Nov 17. Trends Cancer. 2023. PMID: 36402738 Free PMC article. Review.

10

Human ILC1s target leukemia stem cells and control development of AML.

Caligiuri M, Li Z, Ma R, Tang H, Zhang J, Marcucci G, Yu J. Caligiuri M, et al. Among authors: li z. Res Sq [Preprint]. 2023 Jan 10:rs.3.rs-2319959. doi: 10.21203/rs.3.rs-2319959/v1. Res Sq. 2023. PMID: 36711868 Free PMC article. Preprint.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103,567 results

Search Page